Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
Running, not enrolling · Phase 2
Conditions studied: Ovarian Cancer, Hepatocellular Carcinoma, Non-small Cell Lung Cancer, Bladder Cancer, Microsatellite Instability-High
In brief
This study will assess the safety and efficacy of DPX-Survivac and low dose cyclophosphamide with pembrolizumab in subjects with selected advanced and recurrent solid tumours.
Key facts
- Study ID
- NCT03836352
- Run by
- ImmunoVaccine Technologies, Inc. (IMV Inc.)
- People needed
- 184
- Starts
- 2018-12-21
- Expected to finish
- 2023-12-31
- Last updated by the study team
- 2022-03-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The University of Arizona Cancer Center — Tucson, Arizona, United States
- Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center — Los Angeles, California, United States
- Boca Raton Regional Hospital, Lynn Cancer Institute — Boca Raton, Florida, United States
- Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
- Comprehensive Hematology and Oncology — St. Petersburg, Florida, United States
- Winship Cancer Institute: The Emory Clinic — Atlanta, Georgia, United States
- James Brown Graham Cancer Center:University of Louisville Hospital — Louisville, Kentucky, United States
- Ochsner Cancer Institute — New Orleans, Louisiana, United States
- Allina Health, Virginia Piper Cancer Institute — Minneapolis, Minnesota, United States
- Christus St. Vincent Regional Cancer Center — Santa Fe, New Mexico, United States
- NYU Winthrop Hospital — Mineola, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- University of Toledo — Toledo, Ohio, United States
- Mary Crowley Cancer Research Center — Dallas, Texas, United States
- MD Anderson — Houston, Texas, United States
- William Osler Health System — Brampton, Ontario, Canada
- Juravinski Cancer Center — Hamilton, Ontario, Canada
- Southlake Regional Health Center — Newmarket, Ontario, Canada
- The Ottawa Hospital — Ottawa, Ontario, Canada
- Sunnybrook Research Institute — Toronto, Ontario, Canada
- Centre hospitalier de l'Université de Montréal (CHUM) — Montreal, Quebec, Canada
- McGill University Health Center — Montreal, Quebec, Canada
- CHU de Québec-Université Laval — Québec, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.